Full Press Release Details
Supernus to Present at Three November Healthcare Conferences
ROCKVILLE, Md., Nov. 08, 2017 Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that the Company s management will present an overview and update for the Company, and host investor meetings at the following three conferences:
Stifel 2017 Healthcare Conference
Date: Tuesday, November 14, 2017
Time: 11:45 a.m. EST
Place: Lotte New York Palace Hotel, New York
Jefferies 2017 London Healthcare Conference
Date: Thursday, November 16, 2017
Time: 4:40 p.m. GMT (11:40 a.m. EST)
Place: Waldorf Hilton, London, U.K.
Piper Jaffray 29th Annual Healthcare Conference
Date: Wednesday, November 29, 2017
Place: Lotte New York Palace Hotel, New York
Investors interested in arranging a meeting with the Company s management during these conferences should contact the conference coordinator.
A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investors Section on the Company s website at www.supernus.com. An archived replay of these webcasts will be available for 60 days on the Company s website after each conference.
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company currently markets Trokendi XR (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, and Oxtellar XR (extended-release oxcarbazepine) for the treatment of epilepsy. The Company is also developing several product candidates to address large market opportunities in psychiatry, including SPN-810 for the treatment of Impulsive Aggression in ADHD patients and SPN-812 for the treatment of ADHD.
Jack A. Khattar, President and CEO
Gregory S. Patrick, Vice President and CFO
Supernus Pharmaceuticals, Inc.
Office: (443) 213-0505
Mobile: (443) 377-4767
Email: peter.vozzo@westwicke.com